🇺🇸 FDA
Pipeline program

HUMAN SERUM ALBUMIN, SODIUM CHLORIDE

LIVER-AKI

Approved small_molecule active

Quick answer

HUMAN SERUM ALBUMIN, SODIUM CHLORIDE for descompensated hepatic cirrosis is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
descompensated hepatic cirrosis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials